Biopharma Biotechnology Contract research organization 
Frost & Sullivan
AUGUST 29, 2024
However, the pharma/biopharma industry overall shows stagnant R&D activity. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8%
Frost & Sullivan
APRIL 25, 2023
April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Jake Jorgovan
JUNE 3, 2024
NDA Partners NDA Partners, a ProPharma Group company, is a leading life sciences management consulting and contract development organization (CDO). They specialize in providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide.
Jake Jorgovan
FEBRUARY 1, 2024
They offer a wealth of expertise in biotechnology, pharmaceuticals, and healthcare, guiding companies through product development, market strategies, and regulatory compliance. The company addresses the challenges faced by pharmaceutical, medical device, biotechnology, and diagnostic firms. market goals for its clients.
Jake Jorgovan
FEBRUARY 2, 2025
They offer a wealth of expertise in biotechnology, pharmaceuticals, and healthcare, guiding companies through product development, market strategies, and regulatory compliance. The company addresses the challenges faced by pharmaceutical, medical device, biotechnology, and diagnostic firms. market goals for its clients.
Expert insights. Personalized for you.
52 
Let's personalize your content